0001206774-20-000346.txt : 20200204 0001206774-20-000346.hdr.sgml : 20200204 20200204064526 ACCESSION NUMBER: 0001206774-20-000346 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20200204 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200204 DATE AS OF CHANGE: 20200204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CLOROX CO /DE/ CENTRAL INDEX KEY: 0000021076 STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842] IRS NUMBER: 310595760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07151 FILM NUMBER: 20570610 BUSINESS ADDRESS: STREET 1: THE CLOROX COMPANY STREET 2: 1221 BROADWAY CITY: OAKLAND STATE: CA ZIP: 94612-1888 BUSINESS PHONE: 5102717000 MAIL ADDRESS: STREET 1: P.O. BOX 24305 CITY: OAKLAND STATE: CA ZIP: 94612-1305 8-K 1 clorox3715881-8k.htm CURRENT REPORT
0000021076 false CLOROX CO /DE/ 0000021076 2020-02-03 2020-02-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 4, 2020

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
____________________

Delaware 1-07151 31-0595760
(State or other jurisdiction of
incorporation)
(Commission File Number) (I.R.S. Employer
Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)

(510) 271-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]   Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading
Symbol(s)
Name of each exchange on which registered
Common Stock - $1.00 par value CLX New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 
 

Item 2.02 Results of Operations and Financial Condition

On February 4, 2020, The Clorox Company issued a press release announcing its financial results for its second quarter ended December 31, 2019. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure

Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

See the Exhibit Index below.

EXHIBIT INDEX

Exhibit       Description
99.1 Press Release dated February 4, 2020 of The Clorox Company
99.2 Supplemental information regarding financial results
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
     

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CLOROX COMPANY
 
Date: February 4, 2020 By:       /s/ Laura Stein
Executive Vice President –
General Counsel and Corporate Affairs
     

EX-99.1 2 clorox3715881-ex991.htm PRESS RELEASE DATED FEBRUARY 4, 2020 OF THE CLOROX COMPANY
PRESS RELEASE
   

Clorox Reports Q2 Fiscal Year 2020 Results, Updates Fiscal Year Outlook

OAKLAND, Calif., Feb. 4, 2020 – The Clorox Company (NYSE:CLX) reported a sales decrease of 2% and an increase in diluted net earnings per share (diluted EPS) of 4% for its second quarter of fiscal year 2020, which ended Dec. 31, 2019.

“I feel good about the progress we’re making, which is reflected in our second-quarter results, particularly the fifth consecutive quarter of gross margin expansion and sequential improvement in organic sales1,” said Chair and CEO Benno Dorer. “We have confidence we’re taking the right steps as we expect to return to growth in the back half of the fiscal year behind strong investments in our robust innovation plans to support distribution. Importantly, we remain committed to strong execution behind our IGNITE strategy to deliver long-term shareholder value.”

This press release includes some non-GAAP financial measures. See "Non-GAAP Financial Information" at the end of this press release for more information.

Fiscal Second-Quarter Results

Following is a summary of key second-quarter results. All comparisons are with the second quarter of fiscal year 2019, unless otherwise stated.

2% sales decrease (flat organic sales)
$1.46 diluted EPS (4% increase)

Sales were down 2%, driven primarily by 2 points of unfavorable foreign currency exchange rates. Organic sales were flat for the quarter.

The company’s second-quarter gross margin increased by 40 basis points to 44.1% from 43.7% in the year-ago quarter. The increase in gross margin was driven primarily by the benefits of cost savings initiatives and price increases, which were partially offset by higher trade promotion spending and manufacturing and logistics costs.

Clorox delivered earnings of $185 million, or $1.46 diluted EPS, compared to $182 million, or $1.40 diluted EPS, in the year-ago quarter, representing a 4% increase in diluted earnings per share. Diluted EPS growth was driven primarily by gross margin expansion.

Year-to-date net cash provided by operations was $498 million, compared to $449 million in the year-ago period — an increase of 11%.

Key Segment Results

Following is a summary of key second-quarter results by reportable segment. All comparisons are with the second quarter of fiscal year 2019, unless otherwise stated.

Cleaning (Laundry, Home Care, Professional Products)

Flat sales
9% pretax earnings increase
____________________

1 Organic sales growth/(decrease) is a non-GAAP measure. See “Non-GAAP Financial Information” at the end of this press release, including the reconciliation of organic sales growth/(decrease) to net sales growth/(decrease), the most comparable GAAP measure.


Segment sales were flat behind growth in Professional Products and Home Care, offset by decreases in Laundry as well as unfavorable mix from strong growth in nontracked channels. Pretax earnings growth was driven mainly by favorable commodity costs, the benefit of cost savings initiatives, and lower manufacturing and logistics costs.

Household (Bags and Wraps, Grilling, Cat Litter, Digestive Health)2

8% sales decrease
20% pretax earnings decrease

Segment sales were down, driven mainly by decreases in the Bags and Wraps and Grilling businesses. In Bags and Wraps, sales decreased due to ongoing distribution losses in select portions of the portfolio and increased competitive activity. In Grilling, sales decreased, as solid consumption growth was more than offset by lower shipments in order to finish working through elevated retail inventory from the prior year. The decrease in pretax earnings was driven mainly by lower sales and higher manufacturing and logistics costs, partially offset by the benefit of cost savings initiatives.

Lifestyle (Dressings and Sauces, Water Filtration, Natural Personal Care, Dietary Supplements)

4% sales increase
9% pretax earnings increase

Segment sales were up, led by Natural Personal Care, which was fueled by innovation in Burt’s Bees Lip Care and Face Care categories. The Food and Water Filtration businesses also contributed to segment sales growth, driven by higher merchandising support for Hidden Valley products and by Brita innovation. Pretax earnings grew primarily behind higher sales.

International (Sales outside of the U.S.)

2% sales decrease (6% organic sales increase)
24% pretax earnings increase

Segment sales were down due to 8 points of negative foreign currency impact, primarily from Argentina, partially offset by the benefit of favorable price mix. On an organic sales basis, International grew 6%. Pretax earnings were up, driven by the benefits of price increases and cost savings, which more than offset the impact of unfavorable foreign currency exchange rates and inflationary pressure on manufacturing and logistics costs.

Clorox Updates Fiscal Year 2020 Outlook

Low single-digit decrease to 1% increase in sales (flat to 2% organic sales growth)
$6.10-$6.25 diluted EPS range (3% to 1% decrease versus year-ago)

Clorox confirms its fiscal year sales outlook of a low single-digit decrease to a 1% increase. The company’s fiscal year sales outlook now reflects a slightly more favorable foreign exchange impact, offset by increased promotional spending to address competitive activity in select categories. Fiscal year organic sales is now expected to be about flat to 2% growth.

Gross margin is now expected to be up slightly, mainly reflecting lower input costs.

Advertising and sales promotion spending is now projected to be slightly more than 10% of sales as the company invests strongly behind robust innovation platforms in the back half of the fiscal year in order to support distribution.

Clorox continues to anticipate selling and administrative expenses to be about 14% of sales.

The company’s effective tax rate is still expected to be in the range of 22%-23%.
____________________

2 During the second quarter of fiscal year 2020, the company’s Charcoal strategic business unit, or SBU, within the Household reportable segment was renamed the Grilling SBU to reflect a broader strategic view of the category. There has been no change to the composition of the Grilling SBU or the Household reportable segment; therefore, no prior periods were restated. 

Page 2 of 9


Net of all these factors, Clorox now anticipates fiscal year 2020 diluted EPS to be between $6.10 and $6.25, reflecting a 5-cent increase to the low end of the range.

“I’m pleased that we remain on track to deliver record annual cost savings as well as strong cash flow for the year, which will help provide the fuel necessary to keep investing in our brands and categories,” said Chief Financial Officer Kevin Jacobsen. “Looking ahead, I believe we’re continuing to take the right actions to generate growth that is more in line with our financial goals as we execute against our IGNITE strategy to drive long-term shareholder value.”

For More Detailed Financial Information

Visit the company’s Financial Information: Quarterly Results section of the company’s website at TheCloroxCompany.com for the following:

Supplemental unaudited volume and sales growth information
Supplemental unaudited gross margin driver information
Supplemental unaudited cash flow information and free cash flow reconciliation
Supplemental unaudited reconciliation of earnings before interest and taxes (EBIT) and earnings before interest, taxes, depreciation and amortization (EBITDA)

Note: Percentage and basis-point changes noted in this press release are calculated based on rounded numbers, except for per-share data and the effective tax rate. Supplemental materials are available in the Financial Information: Quarterly Results section of the company’s website at TheCloroxCompany.com.

The Clorox Company

The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with approximately 8,800 employees worldwide and fiscal year 2019 sales of $6.2 billion. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products; Pine-Sol® cleaners; Liquid-Plumr® clog removers; Poett® home care products; Fresh Step® cat litter; Glad® bags, wraps and containers; Kingsford® charcoal; Hidden Valley® dressings and sauces; Brita® water-filtration products; Burt's Bees® natural personal care products; RenewLife® digestive health products; and Rainbow Light®, Natural Vitality™ and NeoCell® dietary supplements. The company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro™ and Clorox Healthcare® brand names. Nearly 80% of the company’s sales are generated from brands that hold the No. 1 or No. 2 market share positions in their categories.

Clorox is a signatory of the United Nations Global Compact and the Ellen MacArthur Foundation’s New Plastics Economy Global Commitment. The company has been broadly recognized for its corporate responsibility efforts, included on CR Magazine's 2019 100 Best Corporate Citizens list, Barron’s 2019 100 Most Sustainable Companies, the Human Rights Campaign’s 2020 Corporate Equality Index and the 2019 Bloomberg Gender Equality Index, among others. In support of its communities, The Clorox Company and its foundations contributed about $12 million in combined cash grants, product donations and cause marketing in fiscal year 2019. For more information, visit TheCloroxCompany.com, including the Good Growth blog, and follow the company on Twitter at @CloroxCo.

Page 3 of 9


Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements involve risks and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “will,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “predicts,” and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance, are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations, or could affect the company’s ability to achieve its strategic goals, are described in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, as updated from time to time in the company’s Securities and Exchange Commission filings. These factors include, but are not limited to: intense competition in the company’s markets; the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences; volatility and increases in commodity costs such as resin, sodium hypochlorite and agricultural commodities, and increases in energy, transportation or other costs; the ability of the company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix; dependence on key customers and risks related to customer consolidation and ordering patterns; risks related to the company’s use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or company information, or service interruptions; the company’s ability to maintain its business reputation and the reputation of its brands and products; risks relating to acquisitions, new ventures and divestitures, and associated costs, including the potential for asset impairment charges related to, among others, intangible assets and goodwill; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions; lower revenue, increased costs or reputational harm resulting from government actions and regulations; the ability of the company to successfully manage global, political, legal, tax and regulatory risks, including changes in regulatory or administrative activity; worldwide, regional and local economic and financial market conditions; risks related to international operations and international trade, including foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls, including periodic changes in such controls; changes in U.S. immigration or trade policies, including the imposition of new or additional tariffs; labor claims and labor unrest; inflationary pressures, particularly in Argentina; political instability and the uncertainty regarding the outcome of Brexit; government-imposed price controls or other regulations; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; and the possibility of nationalization, expropriation of assets or other government action; the ability of the company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries; the impact of product liability claims, labor claims and other legal or tax proceedings, including in foreign jurisdictions; the ability of the company to implement and generate cost savings and efficiencies; the success of the company’s business strategies; risks related to additional increases in the estimated fair value of The Procter & Gamble Company’s interest in the Glad® business; the company’s ability to attract and retain key personnel; supply disruptions and other risks inherent in reliance on a limited base of suppliers; environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; increased focus by governmental and non-governmental organizations, customers, consumers and investors on sustainability issues, including those related to climate change; the facilities of the company and its suppliers being subject to disruption by events beyond the company’s control, including work stoppages, cyber-attacks, natural disasters and terrorism; the company’s ability to maximize, assert and defend its intellectual property rights; any infringement or claimed infringement by the company of third-party intellectual property rights; the accuracy of the company’s estimates and assumptions on which its financial projections are based; the effect of the company’s indebtedness and credit rating on its business operations and financial results; the company’s ability to pay and declare dividends or repurchase its stock in the future; uncertainties relating to tax positions, tax disputes and changes in the company’s tax rate, and any additional effects of the Tax Cuts and Jobs Act on the company; the company’s ability to maintain an effective system of internal controls; the impacts of potential stockholder activism; and risks related to the company’s discontinuation of operations in Venezuela.

Page 4 of 9


The company’s forward-looking statements in this press release are based on management’s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

Non-GAAP Financial Information

This press release contains non-GAAP financial information related to organic sales growth/(decrease) for the second quarter of fiscal year 2020 and organic sales growth outlook for fiscal year 2020. Clorox defines organic sales growth/(decrease) as GAAP net sales growth/(decrease) excluding the effect of foreign exchange rate changes and any acquisitions or divestitures.
Organic sales growth outlook for fiscal year 2020 excludes the impact of unfavorable foreign currency exchange rates, which the company expects could reduce GAAP net sales growth by about 2 percentage points.
Management believes that the presentation of organic sales growth/(decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the company was operating and expects to operate throughout the relevant periods, and the company’s estimate of the impact of foreign exchange rate changes, which are difficult to predict and out of the control of the company and management. However, organic sales growth/(decrease) may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded.

The following tables provide reconciliation of organic sales growth/(decrease) (non-GAAP) to net sales growth/(decrease) (GAAP), the most comparable GAAP measure:

Three Months Ended December 31, 2019 (Q2 of Fiscal Year 2020)
Percentage change versus the year-ago period
      Cleaning       Household       Lifestyle       International       Total
Net sales growth / (decrease) (GAAP) % (8)% 4% (2)% (2)%
Add: Foreign Exchange 8 2
Add/(Subtract): Divestitures/Acquisitions
Organic sales growth / (decrease) (non-GAAP) % (8)% 4% 6% %
 
Six Months Ended December 31, 2019
Percentage change versus the year-ago period
Cleaning Household Lifestyle International Total
Net sales growth / (decrease) (GAAP) (1)% (11)% 4% (1)% (3)%
Add: Foreign Exchange 8 2
Add/(Subtract): Divestitures/Acquisitions
Organic sales growth / (decrease) (non-GAAP) (1)% (11)% 4% 7% (1)%

Page 5 of 9



Three Months Ended September 30, 2019 (Q1 of Fiscal Year 2020)
Percentage change versus the year-ago period
      Cleaning       Household       Lifestyle       International       Total
Net sales growth / (decrease) (GAAP) (2)% (14)% 4% % (4)%
Add: Foreign Exchange 8 2
Add/(Subtract): Divestitures/Acquisitions
Organic sales growth / (decrease) (non-GAAP) (2)% (14)% 4% 8% (2)%

Media Relations

Naomi Greer 510-271-7892, naomi.greer@clorox.com
Aileen Zerrudo 510-271-3075, aileen.zerrudo@clorox.com

Investor Relations

Lisah Burhan 510-271-3269, lisah.burhan@clorox.com
Joel Ramirez 510-271-3012, joel.ramirez@clorox.com

For recent presentations made by company management and other investor materials, visit Investor Events on the company’s website.

Page 6 of 9


Condensed Consolidated Statements of Earnings (Unaudited)
Dollars in millions, except share and per share data

Three Months Ended Six Months Ended
12/31/2019 12/31/2018 12/31/2019 12/31/2018
Net sales       $ 1,449       $ 1,473       $ 2,955       3,036
Cost of products sold 810 830 1,653 1,715
Gross profit 639 643 1,302 1,321
 
Selling and administrative expenses 210 211 421 423
Advertising costs 140 145 277 284
Research and development costs 34 32 64 64
Interest expense 25 24 50 48
Other (income) expense, net (5 ) 7 (3 ) 10
Earnings before income taxes 235 224 493 492
Income taxes 50 42 105 100
Net earnings $ 185 $ 182 $ 388 $ 392
 
Net earnings per share
Basic net earnings per share $ 1.48 $ 1.42 $ 3.09 $ 3.07
Diluted net earnings per share $ 1.46 $ 1.40 $ 3.05 $ 3.02
 
Weighted average shares outstanding (in thousands)
Basic 125,440 128,068 125,632 127,955
Diluted 126,879 130,094 127,198 130,107

Page 7 of 9


Reportable Segment Information
(Unaudited)
Dollars in millions

Net sales Earnings (losses) before income taxes
Three Months Ended Three Months Ended
12/31/2019 12/31/2018 % Change(1) 12/31/2019 12/31/2018 % Change(1)
Cleaning       $ 501       $ 500       -       $ 147       $ 135       9%
Household 360 393 -8% 37 46 -20%
Lifestyle 347 335 4% 85 78 9%
International 241 245 -2% 31 25 24%
Corporate - - - (65 ) (60 ) 8%
Total $ 1,449 $ 1,473 -2% $   235 $ 224 5%
 
Net sales Earnings (losses) before income taxes
Six Months Ended Six Months Ended
12/31/2019 12/31/2018 % Change(1) 12/31/2019 12/31/2018 % Change(1)
Cleaning $ 1,063 $ 1,071 -1% $ 325 $ 315 3%
Household 741 835 -11% 62 105          -41%
Lifestyle 669 644 4% 155 140 11%
International 482 486 -1% 70 53 32%
Corporate - - - (119 ) (121 ) -2%
Total $ 2,955 $ 3,036 -3% $ 493 $ 492 -

(1) Percentages based on rounded numbers.

Page 8 of 9


Condensed Consolidated Balance Sheets
Dollars in millions

12/31/2019 6/30/2019 12/31/2018
(Unaudited) (Unaudited)
ASSETS
Current assets
Cash and cash equivalents       $ 168       $ 111       $ 162
Receivables, net 544 631 528
Inventories, net 514 512 578
Prepaid expenses and other current assets 77 51 97
Total current assets 1,303 1,305 1,365
Property, plant and equipment, net 1,052 1,034 992
Operating lease right-of-use assets 303 - -
Goodwill 1,588 1,591 1,586
Trademarks, net 790 791 792
Other intangible assets, net 115 121 127
Other assets 308 274 211
Total assets $ 5,459 $ 5,116 $ 5,073
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Notes and loans payable $ 507 $ 396 $ 235
Current operating lease liabilities 61 - -
Accounts payable and accrued liabilities 945 1,035 951
Income taxes payable - 9 -
Total current liabilities 1,513 1,440 1,186
Long-term debt 2,288 2,287 2,285
Long-term operating lease liabilities 282 - -
Other liabilities 745 780 789
Deferred income taxes 76 50 71
Total liabilities 4,904 4,557 4,331
 
Stockholders’ equity
Preferred stock - - -
Common stock 159 159 159
Additional paid-in capital 1,062 1,046 1,014
Retained earnings 3,292 3,150 2,940
Treasury shares (3,357 ) (3,194 ) (2,794 )
Accumulated other comprehensive net (loss) income (601 ) (602 ) (577 )
Stockholders’ equity 555 559 742
Total liabilities and stockholders’ equity $       5,459 $    5,116 $       5,073

Page 9 of 9


EX-99.2 3 clorox3715881-ex992.htm SUPPLEMENTAL INFORMATION REGARDING FINANCIAL RESULTS
The Clorox Company

Three Months Ended December 31, 2019
Percentage change versus the year-ago period
Reported
(GAAP)
Net Sales
Growth/
(Decrease)
Reported
Volume
Acquisitions
&
Divestitures
Foreign
Exchange
Impact
Price
Mix and
Other (1)
Organic
Net Sales
Growth/
(Decrease)
(Non-
GAAP)
(2)
Organic
Volume
(3)
Cleaning —% 1% —% —% (1%) —% 2%
Household (8) (5) (3) (8) (5)
Lifestyle 4 4 4 4
International (2) (1) (8) 7 6 (1)
Total (2%) —% —% (2%) —% —% —%

Six Months Ended December 31, 2019
Percentage change versus the year-ago period
Reported
(GAAP)
Net Sales
Growth/
(Decrease)
Reported
Volume
Acquisitions
&
Divestitures
Foreign
Exchange
Impact
Price
Mix and
Other (1)
Organic
Net Sales
Growth/
(Decrease)
(Non-
GAAP)
(2)
Organic
Volume
(3)
Cleaning (1%) 1% —% —% (2%) (1%) 1%
Household (11) (6) (5) (11) (6)
Lifestyle 4 4 4 4
International (1) 1 (8) 6 7 1
Total (3%) —% —% (2%) (1%) (1%) —%

(1)

This represents the net impact on net sales growth/ (decrease) from pricing action, mix and other factors.

(2)

Organic sales growth/ (decrease) is defined as net sales growth/ (decrease) excluding the effect of any acquisitions and divestitures and foreign exchange rate changes. See “Non-GAAP Financial Information” below for reconciliation of organic sales growth to net sales growth/ (decrease), the most directly comparable GAAP financial information.

(3)

Organic volume represents volume excluding the effect of any acquisitions and divestitures.

Non-GAAP Financial Information
Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the company was operating throughout the relevant periods, and the impact of foreign exchange rate changes, which are out of the control of the company and management. However, organic sales growth / (decrease) may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded.



The Clorox Company

The following table provides a reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease) (GAAP), the most comparable GAAP measure:

Three Months Ended December 31, 2019
Percentage change versus the year-ago period
      Cleaning       Household       Lifestyle       International       Total
Net sales growth / (decrease) (GAAP) —% (8%) 4% (2%) (2%)
Add: Foreign Exchange 8 2
Add/(Subtract): Divestitures/Acquisitions
Organic sales growth / (decrease) (non-GAAP) —% (8%) 4% 6% —%
                     
Six Months Ended December 31, 2019
P
ercentage change versus the year-ago period
Cleaning Household Lifestyle International Total
Net sales growth / (decrease) (GAAP) (1%) (11%) 4% (1%) (3%)
Add: Foreign Exchange 8 2
Add/(Subtract): Divestitures/Acquisitions
Organic sales growth / (decrease) (non-GAAP) (1%) (11%) 4% 7% (1%)



The Clorox Company

Supplemental Unaudited Condensed Information – Gross Margin Drivers

The table below provides details on the drivers of gross margin change versus the prior year.

Gross Margin Change vs. Prior Year (basis points)
Driver FY19 FY20
Q1 Q2 Q3 Q4 FY Q1 Q2
Cost Savings +130 +140 +170 +150 +150 +180 +150
Price Changes +90 +220 +240 +220 +190 +120 +100
Market Movement (commodities) -130 -120 -50 +20 -60 +30 +60
Manufacturing & Logistics -280 -190 -190 -90 -190 -50 -80
All other (1,2,3,4) +40 +20 -110 -190 -70 -220 -190
Change vs prior year -150 +70 +60 +110 +20 +60 +40
               
Gross Margin (%) 43.4% 43.7% 43.4% 45.1% 43.9% 44.0% 44.1%

(1) In Q3 of fiscal year 2019, “All other” includes about -70bps of negative impact from foreign exchange.
(2) In Q4 of fiscal year 2019, “All other” includes about -150bps of negative impact from higher trade promotion spending.
(3) In Q1 of fiscal year 2020, “All other” includes about -180bps of negative impact from higher trade promotion spending.
(4) In Q2 of fiscal year 2020, “All other” includes about -90bps of negative impact from higher trade promotion spending.



The Clorox Company

Supplemental Unaudited Condensed Information – Cash Flow
For the quarter ended December 31, 2019

Capital expenditures for the second quarter were $57 million versus $50 million in the year-ago quarter.

Depreciation and amortization expense for the second quarter was $44 million versus $44 million in the year-ago quarter.

Net cash provided by operations in the second quarter was $227 million, or 15.7% of net sales.

Supplemental Unaudited Condensed Information – Free Cash Flow
Fiscal Year Free Cash Flow Reconciliation

Dollars in Millions and percentages based on rounded numbers

Q2 Fiscal
YTD 2020
Q2 Fiscal
YTD 2019
Net cash provided by operations – GAAP $498 $449
Less: Capital expenditures       $111       $86
Free cash flow – non-GAAP (1) $387 $363
Free cash flow as a percentage of net sales – non-GAAP (1) 13.1% 12.0%
Net sales $2,955 $3,036

(1)

In accordance with the SEC's Regulation G, this schedule provides the definition of certain non-GAAP measures and the reconciliation to the most closely related GAAP measure. Management uses free cash flow and free cash flow as a percentage of net sales to help assess the cash generation ability of the business and funds available for investing activities, such as acquisitions, investing in the business to drive growth, and financing activities, including debt payments, dividend payments and stock repurchases. Free cash flow does not represent cash available only for discretionary expenditures, since the Company has mandatory debt service requirements and other contractual and non-discretionary expenditures. In addition, free cash flow may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded.

These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures and should be read in connection with the company’s consolidated financial statements presented in accordance with GAAP.




The Clorox Company

Supplemental Unaudited Reconciliation of Earnings Before Income Taxes to EBIT(1)(3) and EBITDA (2)(3)

Dollars in Millions and percentages based on rounded numbers

FY 2019 FY 2020
         
Q1
9/30/18
Q2
12/31/18
Q3
3/31/19
Q4
6/30/19
FY
6/30/19
Q1
9/30/19
Q2
12/31/19
Earnings before income taxes       $268    $224    $240    $292    $1,024    $258    $235
Interest income -$1 $0 -$1 -$1 -$3 $0 -$1
Interest expense $24 $24 $24 $25 $97 $25 $25
EBIT (1)(3) $291 $248 $263 $316 $1,118 $283 $259
EBIT margin (1)(3) 18.6% 16.8% 17.0% 19.4% 18.0% 18.8% 17.9%
Depreciation and amortization $44 $44 $45 $47 $180 $44 $44
EBITDA (2)(3) $335 $292 $308 $363 $1,298 $327 $303
EBITDA margin (2)(3) 21.4% 19.8% 19.9% 22.3% 20.9% 21.7% 20.9%
Net sales $1,563 $1,473 $1,551 $1,627 $6,214 $1,506 $1,449
Total debt (4) $2,565 $2,520 $2,607 $2,683 $2,683 $2,736 $2,795
Debt to EBITDA (3)(5) 2.0 1.9 2.0 2.1 2.1 2.1 2.1

(1)

EBIT (a non-GAAP measure) represents earnings before income taxes (a GAAP measure), excluding interest income and interest expense, as reported above. EBIT margin is the ratio of EBIT to net sales.

(2)

EBITDA (a non-GAAP measure) represents earnings from before income taxes (a GAAP measure), excluding interest income, interest expense, depreciation and amortization, as reported above. EBITDA margin is the ratio of EBITDA to net sales.

(3)

In accordance with the SEC's Regulation G, this schedule provides the definition of certain non-GAAP measures and the reconciliation to the most closely related GAAP measure. Management believes the presentation of EBIT, EBIT margin, EBITDA, EBITDA margin and debt to EBITDA provides useful additional information to investors about trends in the company's operations and is useful for period-over-period comparisons. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read in connection with the company’s consolidated financial statements presented in accordance with GAAP.

(4)

Total debt represents the sum of notes and loans payable, current maturities of long-term debt and long-term debt. Current maturities of long-term debt and long-term debt are carried at face value net of unamortized discounts, premiums and debt issuance costs.

(5)

Debt to EBITDA (a non-GAAP measure) represents total debt divided by EBITDA for the trailing four quarters.



EX-101.SCH 4 clx-20200204.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.PRE 5 clx-20200204_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.LAB 6 clx-20200204_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Information, Former Legal or Registered Name GRAPHIC 7 clorox3715881-ex992x1x1.jpg GRAPHIC begin 644 clorox3715881-ex992x1x1.jpg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�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end JSON 8 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "clorox3715881-8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "clorox3715881-8k.htm" ] }, "labelLink": { "local": [ "clx-20200204_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "clx-20200204_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "clx-20200204.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 60, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "CLX", "nsuri": "http://thecloroxcompany.com/20200204", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "body", "html" ], "baseRef": "clorox3715881-8k.htm", "contextRef": "From2020-02-03to2020-02-04", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://thecloroxcompany.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "body", "html" ], "baseRef": "clorox3715881-8k.htm", "contextRef": "From2020-02-03to2020-02-04", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r9" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r11": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r12": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r13": { "Name": "Forms 10-K, 20-F, 40-F", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-1" }, "r14": { "Name": "Forms 20-F, 40-F", "Number": "249", "Publisher": "SEC", "Section": "220 and 240", "Subsection": "f" }, "r15": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r18": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" } }, "version": "2.1" } XML 9 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Cover
Feb. 04, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 04, 2020
Entity File Number 1-07151
Entity Registrant Name CLOROX CO /DE/
Entity Central Index Key 0000021076
Entity Tax Identification Number 31-0595760
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1221 Broadway
Entity Address, City or Town Oakland
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94612-1888
City Area Code 510
Local Phone Number 271-7000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock - $1.00 par value
Trading Symbol CLX
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Information, Former Legal or Registered Name Not applicable
XML 12 clorox3715881-8k_htm.xml IDEA: XBRL DOCUMENT 0000021076 2020-02-03 2020-02-04 iso4217:USD shares iso4217:USD shares 0000021076 false CLOROX CO /DE/ 8-K 2020-02-04 DE 1-07151 31-0595760 1221 Broadway Oakland CA 94612-1888 510 271-7000 Not applicable false false false false Common Stock - $1.00 par value CLX NYSE false XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 1 95 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://thecloroxcompany.com/role/Cover Cover Cover 1 false false All Reports Book All Reports clorox3715881-8k.htm clorox3715881-ex991.htm clorox3715881-ex992.htm clx-20200204.xsd clx-20200204_lab.xml clx-20200204_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 16 0001206774-20-000346-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001206774-20-000346-xbrl.zip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end XML 17 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}